Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT00935792 · COMPLETED
Trial details
- NCT number
- NCT00935792
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2015-12-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.